The combination between PD-L1 and PD-1 induces deactivation, apoptosis, and depletion of T cells, which in turn inhibits the activation, proliferation and anti-tumor function of tumor antigen-specific CD8 + T cells. The gene discussed is PDCD1; the disease is neoplasm.